WELLS FARGO & COMPANY/MN
Position in ABOS — Acumen Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in ABOS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$23,854
+$8,873 QoQ
Shares Held
10,108
+42.4% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 84 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,293,431,965 across 386 Biotechnology names. ABOS ranks #264 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in ABOS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,854 | 10,108 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $14,981 | 7,100 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $11,115 | 6,500 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,917 | 6,825 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $30,445 | 27,678 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $44,924 | 26,119 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $52,719 | 21,258 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $49,443 | 20,431 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,892 | 1,208 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $8,467 | 2,205 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $805 | 194 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,105 | 2,101 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $12,569 | 3,096 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $9,681 | 1,793 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $20,962 | 2,090 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,679 | 570 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,842 | 2,773 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,027 | 2,075 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $757 | 51 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||